These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16373459)

  • 1. Genotyping systems for drug-metabolizing enzymes go clinical.
    Thompson CA
    Am J Health Syst Pharm; 2006 Jan; 63(1):12, 14, 16. PubMed ID: 16373459
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical devices; clinical chemistry and clinical toxicology devices; drug metabolizing enzyme genotyping system. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Mar; 70(46):11865-7. PubMed ID: 15762010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping for drug-metabolizing enzymes--does the promise meet the reality?
    Gardiner SJ; Begg EJ
    Pharmacogenomics; 2004 Dec; 5(8):1033-6. PubMed ID: 15584874
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic polymorphisms of drug-metabolizing enzymes: molecular mechanisms.
    Meyer UA; Zanger U; Skoda R; Grant DM
    Psychopharmacol Ser; 1989; 7():141-7. PubMed ID: 2687852
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting individual differences in drug-metabolizing enzymes.
    Nagata K
    Drug Metab Pharmacokinet; 2008; 23(1):1. PubMed ID: 18305368
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomics and personalized medicine.
    Meadows M
    FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113
    [No Abstract]   [Full Text] [Related]  

  • 7. Interethnic differences in drug metabolism.
    Goh BC
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):559-61. PubMed ID: 18820596
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions.
    Remmel RP; Burchell B
    Biochem Pharmacol; 1993 Aug; 46(4):559-66. PubMed ID: 8363629
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 10. How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.
    Meisel C; Roots I; Cascorbi I; Brinkmann U; Brockmöller J
    Clin Chem Lab Med; 2000 Sep; 38(9):869-76. PubMed ID: 11097342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to lung cancer--relevance to smoking].
    Uematsu F
    Nihon Rinsho; 1996 Feb; 54(2):513-7. PubMed ID: 8838107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
    Hewitt NJ; de Kanter R; LeCluyse E
    Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
    Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
    Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new series of review articles on drug metabolizing enzymes: nomenclature of isoenzyme families, genetic organization, polymorphisms, substrate specificities, clinical relevance and role in carcinogenesis.
    Bolt HM; Hengstler JG
    Arch Toxicol; 2008 Jul; 82(7):413-4. PubMed ID: 18528684
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
    Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
    Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 18. Current knowledge of microRNA-mediated regulation of drug metabolism in humans.
    Nakano M; Nakajima M
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):493-504. PubMed ID: 29718737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.
    Pan Y; Hsu V; Grimstein M; Zhang L; Arya V; Sinha V; Grillo JA; Zhao P
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S122-31. PubMed ID: 27385170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; clinical chemistry and clinical toxicology devices; classification of the cardiac allograft gene expression profiling test systems.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Oct; 74(202):53883-5. PubMed ID: 19877379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.